[LGND] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 388.63%
YoY- 372.66%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 30,978 43,979 45,693 55,150 33,161 43,484 56,157 -9.43%
PBT 113,447 55,536 -20,140 5,764 -30,415 842,713 55,312 12.70%
Tax 27,308 11,922 -4,755 -12,342 -6,284 176,376 10,033 18.14%
NP 86,139 41,949 -15,385 18,106 -24,131 666,337 45,279 11.30%
Tax Rate -24.07% -21.47% - 214.12% - -20.93% -18.14% -
Total Cost -55,161 2,030 61,078 37,044 57,292 -622,853 10,878 -
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 278.07 95.38 -33.67 32.83 -72.77 1,532.37 80.63 22.89%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS 4.86 2.46 -0.92 1.10 -1.46 32.59 2.13 14.72%
EPS Diluted 4.75 2.33 -0.91 1.05 -1.46 31.32 1.83 17.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.